Publications in collaboration with researchers from Institut Jean Godinot (1)

2020

  1. Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study

    The Lancet Oncology, Vol. 21, Núm. 11, pp. 1513-1525